Cancer Vaccines Market 2027 By Technology, Type, Indication, End User | The Insight Partners

Cancer Vaccines Market to 2027 - Global Analysis and Forecasts by Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector Cancer Vaccines.); Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); Indication (Cervical Cancer, Prostate Cancer, Other Indications); End User (Pediatrics, Adults.)

Report Code: TIPRE00004595 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Cancer Vaccines are vaccines developed for prevention of cancer types and also as a therapeutic treatment to treat existing cancer across a range of indications in oncology, either as standalone therapy or in combination with traditional cancer therapeutics such as chemotherapy and surgery.

MARKET DYNAMICS
The Cancer Vaccines market is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of human papilloma virus infections, administration of prophylactic cancer vaccines, high investments and government funding in development of cancer vaccines, launch of new cancer vaccines, and advancements in the cancer vaccines. Nevertheless, frequent upgradation in manufacturing technology and longer time span required for manufacturing of a single vaccine is expected to hamper the growth of the market during the forecast period.

MARKET SCOPE
The "Global Cancer Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Cancer Vaccines market with detailed market segmentation by Technology, Type, Indication, End User and geography. The global Cancer Vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Cancer Vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Cancer Vaccines market is segmented on the basis of Technology, Type, Indication and End User. Based on technology the market is segmented into Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines, and Viral Vector Cancer Vaccines. Based on Type the market is segmented into Preventive Cancer Vaccines, Therapeutic Cancer Vaccines. Based on Indication the market is segmented into Cervical Cancer, Prostate Cancer and Other Indications. Based on End User the market is segmented into Pediatrics and Adults.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Cancer Vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cancer Vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Cancer Vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cancer Vaccines market in these regions.

MARKET PLAYERS
The reports cover key developments in the Cancer Vaccines Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Cancer Vaccines Market are anticipated to lucrative growth opportunities in the future with the rising demand for Cancer Vaccines in the global market. Below mentioned is the list of few companies engaged in the Cancer Vaccines market.

The report also includes the profiles of key Cancer Vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AstraZeneca
  • GlaxoSmithKline plc.
  • Aduro Biotech Inc
  • Pfizer Inc.
  • Sanofi
  • Bristol-Myers Squibb
  • Moderna, Inc.
  • OncBioMune Pharmaceuticals Inc.
  • MaxiVAX
  • Nouscom
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Vaccines Market - By Technology
1.3.2 Cancer Vaccines Market - By Type
1.3.3 Cancer Vaccines Market - By Indication
1.3.4 Cancer Vaccines Market - By End User
1.3.5 Cancer Vaccines Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. CANCER VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CANCER VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CANCER VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER VACCINES - GLOBAL MARKET OVERVIEW
6.2. CANCER VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. DENDRITIC CELLS CANCER VACCINES
7.3.1. Overview
7.3.2. Dendritic Cells Cancer Vaccines Market Forecast and Analysis
7.4. RECOMBINANT CANCER VACCINES
7.4.1. Overview
7.4.2. Recombinant Cancer Vaccines Market Forecast and Analysis
7.5. ANTIGEN CANCER VACCINES
7.5.1. Overview
7.5.2. Antigen Cancer Vaccines Market Forecast and Analysis
7.6. WHOLE CELL CANCER VACCINES
7.6.1. Overview
7.6.2. Whole Cell Cancer Vaccines Market Forecast and Analysis
7.7. VIRAL VECTOR CANCER VACCINES.
7.7.1. Overview
7.7.2. Viral Vector Cancer Vaccines. Market Forecast and Analysis
8. CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. PREVENTIVE CANCER VACCINES
8.3.1. Overview
8.3.2. Preventive Cancer Vaccines Market Forecast and Analysis
8.4. THERAPEUTIC CANCER VACCINES
8.4.1. Overview
8.4.2. Therapeutic Cancer Vaccines Market Forecast and Analysis
9. CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
9.1. OVERVIEW
9.2. INDICATION MARKET FORECASTS AND ANALYSIS
9.3. CERVICAL CANCER
9.3.1. Overview
9.3.2. Cervical Cancer Market Forecast and Analysis
9.4. PROSTATE CANCER
9.4.1. Overview
9.4.2. Prostate Cancer Market Forecast and Analysis
9.5. OTHER INDICATIONS
9.5.1. Overview
9.5.2. Other Indications Market Forecast and Analysis
10. CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PEDIATRICS
10.3.1. Overview
10.3.2. Pediatrics Market Forecast and Analysis
10.4. ADULTS.
10.4.1. Overview
10.4.2. Adults. Market Forecast and Analysis
11. CANCER VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Cancer Vaccines Market Overview
11.1.2 North America Cancer Vaccines Market Forecasts and Analysis
11.1.3 North America Cancer Vaccines Market Forecasts and Analysis - By Technology
11.1.4 North America Cancer Vaccines Market Forecasts and Analysis - By Type
11.1.5 North America Cancer Vaccines Market Forecasts and Analysis - By Indication
11.1.6 North America Cancer Vaccines Market Forecasts and Analysis - By End User
11.1.7 North America Cancer Vaccines Market Forecasts and Analysis - By Countries
11.1.7.1 United States Cancer Vaccines Market
11.1.7.1.1 United States Cancer Vaccines Market by Technology
11.1.7.1.2 United States Cancer Vaccines Market by Type
11.1.7.1.3 United States Cancer Vaccines Market by Indication
11.1.7.1.4 United States Cancer Vaccines Market by End User
11.1.7.2 Canada Cancer Vaccines Market
11.1.7.2.1 Canada Cancer Vaccines Market by Technology
11.1.7.2.2 Canada Cancer Vaccines Market by Type
11.1.7.2.3 Canada Cancer Vaccines Market by Indication
11.1.7.2.4 Canada Cancer Vaccines Market by End User
11.1.7.3 Mexico Cancer Vaccines Market
11.1.7.3.1 Mexico Cancer Vaccines Market by Technology
11.1.7.3.2 Mexico Cancer Vaccines Market by Type
11.1.7.3.3 Mexico Cancer Vaccines Market by Indication
11.1.7.3.4 Mexico Cancer Vaccines Market by End User
11.1.7.4 US Cancer Vaccines Market
11.1.7.4.1 US Cancer Vaccines Market by Technology
11.1.7.4.2 US Cancer Vaccines Market by Type
11.1.7.4.3 US Cancer Vaccines Market by Indication
11.1.7.4.4 US Cancer Vaccines Market by End User
11.2. EUROPE
11.2.1 Europe Cancer Vaccines Market Overview
11.2.2 Europe Cancer Vaccines Market Forecasts and Analysis
11.2.3 Europe Cancer Vaccines Market Forecasts and Analysis - By Technology
11.2.4 Europe Cancer Vaccines Market Forecasts and Analysis - By Type
11.2.5 Europe Cancer Vaccines Market Forecasts and Analysis - By Indication
11.2.6 Europe Cancer Vaccines Market Forecasts and Analysis - By End User
11.2.7 Europe Cancer Vaccines Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Cancer Vaccines Market
11.2.7.1.1 Germany Cancer Vaccines Market by Technology
11.2.7.1.2 Germany Cancer Vaccines Market by Type
11.2.7.1.3 Germany Cancer Vaccines Market by Indication
11.2.7.1.4 Germany Cancer Vaccines Market by End User
11.2.7.2 France Cancer Vaccines Market
11.2.7.2.1 France Cancer Vaccines Market by Technology
11.2.7.2.2 France Cancer Vaccines Market by Type
11.2.7.2.3 France Cancer Vaccines Market by Indication
11.2.7.2.4 France Cancer Vaccines Market by End User
11.2.7.3 Italy Cancer Vaccines Market
11.2.7.3.1 Italy Cancer Vaccines Market by Technology
11.2.7.3.2 Italy Cancer Vaccines Market by Type
11.2.7.3.3 Italy Cancer Vaccines Market by Indication
11.2.7.3.4 Italy Cancer Vaccines Market by End User
11.2.7.4 Spain Cancer Vaccines Market
11.2.7.4.1 Spain Cancer Vaccines Market by Technology
11.2.7.4.2 Spain Cancer Vaccines Market by Type
11.2.7.4.3 Spain Cancer Vaccines Market by Indication
11.2.7.4.4 Spain Cancer Vaccines Market by End User
11.2.7.5 United Kingdom Cancer Vaccines Market
11.2.7.5.1 United Kingdom Cancer Vaccines Market by Technology
11.2.7.5.2 United Kingdom Cancer Vaccines Market by Type
11.2.7.5.3 United Kingdom Cancer Vaccines Market by Indication
11.2.7.5.4 United Kingdom Cancer Vaccines Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Cancer Vaccines Market Overview
11.3.2 Asia-Pacific Cancer Vaccines Market Forecasts and Analysis
11.3.3 Asia-Pacific Cancer Vaccines Market Forecasts and Analysis - By Technology
11.3.4 Asia-Pacific Cancer Vaccines Market Forecasts and Analysis - By Type
11.3.5 Asia-Pacific Cancer Vaccines Market Forecasts and Analysis - By Indication
11.3.6 Asia-Pacific Cancer Vaccines Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Cancer Vaccines Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Cancer Vaccines Market
11.3.7.1.1 Australia Cancer Vaccines Market by Technology
11.3.7.1.2 Australia Cancer Vaccines Market by Type
11.3.7.1.3 Australia Cancer Vaccines Market by Indication
11.3.7.1.4 Australia Cancer Vaccines Market by End User
11.3.7.2 China Cancer Vaccines Market
11.3.7.2.1 China Cancer Vaccines Market by Technology
11.3.7.2.2 China Cancer Vaccines Market by Type
11.3.7.2.3 China Cancer Vaccines Market by Indication
11.3.7.2.4 China Cancer Vaccines Market by End User
11.3.7.3 India Cancer Vaccines Market
11.3.7.3.1 India Cancer Vaccines Market by Technology
11.3.7.3.2 India Cancer Vaccines Market by Type
11.3.7.3.3 India Cancer Vaccines Market by Indication
11.3.7.3.4 India Cancer Vaccines Market by End User
11.3.7.4 Japan Cancer Vaccines Market
11.3.7.4.1 Japan Cancer Vaccines Market by Technology
11.3.7.4.2 Japan Cancer Vaccines Market by Type
11.3.7.4.3 Japan Cancer Vaccines Market by Indication
11.3.7.4.4 Japan Cancer Vaccines Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Cancer Vaccines Market Overview
11.4.2 Middle East and Africa Cancer Vaccines Market Forecasts and Analysis
11.4.3 Middle East and Africa Cancer Vaccines Market Forecasts and Analysis - By Technology
11.4.4 Middle East and Africa Cancer Vaccines Market Forecasts and Analysis - By Type
11.4.5 Middle East and Africa Cancer Vaccines Market Forecasts and Analysis - By Indication
11.4.6 Middle East and Africa Cancer Vaccines Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Cancer Vaccines Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Cancer Vaccines Market
11.4.7.1.1 South Africa Cancer Vaccines Market by Technology
11.4.7.1.2 South Africa Cancer Vaccines Market by Type
11.4.7.1.3 South Africa Cancer Vaccines Market by Indication
11.4.7.1.4 South Africa Cancer Vaccines Market by End User
11.4.7.2 Saudi Arabia Cancer Vaccines Market
11.4.7.2.1 Saudi Arabia Cancer Vaccines Market by Technology
11.4.7.2.2 Saudi Arabia Cancer Vaccines Market by Type
11.4.7.2.3 Saudi Arabia Cancer Vaccines Market by Indication
11.4.7.2.4 Saudi Arabia Cancer Vaccines Market by End User
11.4.7.3 U.A.E Cancer Vaccines Market
11.4.7.3.1 U.A.E Cancer Vaccines Market by Technology
11.4.7.3.2 U.A.E Cancer Vaccines Market by Type
11.4.7.3.3 U.A.E Cancer Vaccines Market by Indication
11.4.7.3.4 U.A.E Cancer Vaccines Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Cancer Vaccines Market Overview
11.5.2 South and Central America Cancer Vaccines Market Forecasts and Analysis
11.5.3 South and Central America Cancer Vaccines Market Forecasts and Analysis - By Technology
11.5.4 South and Central America Cancer Vaccines Market Forecasts and Analysis - By Type
11.5.5 South and Central America Cancer Vaccines Market Forecasts and Analysis - By Indication
11.5.6 South and Central America Cancer Vaccines Market Forecasts and Analysis - By End User
11.5.7 South and Central America Cancer Vaccines Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Cancer Vaccines Market
11.5.7.1.1 Brazil Cancer Vaccines Market by Technology
11.5.7.1.2 Brazil Cancer Vaccines Market by Type
11.5.7.1.3 Brazil Cancer Vaccines Market by Indication
11.5.7.1.4 Brazil Cancer Vaccines Market by End User
11.5.7.2 Argentina Cancer Vaccines Market
11.5.7.2.1 Argentina Cancer Vaccines Market by Technology
11.5.7.2.2 Argentina Cancer Vaccines Market by Type
11.5.7.2.3 Argentina Cancer Vaccines Market by Indication
11.5.7.2.4 Argentina Cancer Vaccines Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CANCER VACCINES MARKET, KEY COMPANY PROFILES
13.1. ASTRAZENECA
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GLAXOSMITHKLINE PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ADURO BIOTECH INC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PFIZER INC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SANOFI
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BRISTOL-MYERS SQUIBB
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. MODERNA, INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ONCBIOMUNE PHARMACEUTICALS INC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MAXIVAX
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NOUSCOM
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

- AstraZeneca
- GlaxoSmithKline plc.
- Aduro Biotech Inc
- Pfizer Inc.
- Sanofi
- Bristol-Myers Squibb
- Moderna, Inc.
- OncBioMune Pharmaceuticals Inc.
- MaxiVAX
- Nouscom